3rd Quarter - Report
WINNING STRATEGIES WASHINGTON for CHARLEY'S FUND
Client
Income
$10,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Implementation of the accelerated approval provision of FDASIA as it pertains to treatments applicable for rare, deadly childhood diseases
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT MACKENZIE | — |
| DONNA MULLINS | — |
| CHELSEY PENROD HICKMAN | — |
Health Issues HCR
Implementation of the accelerated approval provision of FDASIA as it pertains to treatments applicable for rare, deadly childhood diseases
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT MACKENZIE | — |
| DONNA MULLINS | — |
| CHELSEY PENROD HICKMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.